IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

FARINI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.781
NA - Nord America 3.398
AS - Asia 2.228
SA - Sud America 97
AF - Africa 19
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 7
Totale 10.547
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.270
GB - Regno Unito 1.471
CN - Cina 967
SE - Svezia 692
IT - Italia 683
DE - Germania 645
SG - Singapore 460
RU - Federazione Russa 295
IN - India 213
UA - Ucraina 204
TR - Turchia 200
FR - Francia 143
IE - Irlanda 143
KR - Corea 141
FI - Finlandia 120
EU - Europa 118
CA - Canada 109
NL - Olanda 107
HK - Hong Kong 98
PL - Polonia 83
CO - Colombia 50
ID - Indonesia 47
BR - Brasile 39
GR - Grecia 38
BE - Belgio 36
DK - Danimarca 26
RO - Romania 22
ES - Italia 19
CH - Svizzera 18
MX - Messico 18
JP - Giappone 15
AU - Australia 13
VN - Vietnam 13
IR - Iran 12
MY - Malesia 10
IL - Israele 9
UZ - Uzbekistan 9
EG - Egitto 8
TW - Taiwan 8
PH - Filippine 7
AT - Austria 6
CL - Cile 5
CZ - Repubblica Ceca 5
NZ - Nuova Zelanda 4
PK - Pakistan 4
SA - Arabia Saudita 4
TH - Thailandia 4
BD - Bangladesh 3
HR - Croazia 3
NO - Norvegia 3
PT - Portogallo 3
SC - Seychelles 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BG - Bulgaria 2
LU - Lussemburgo 2
MA - Marocco 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
AO - Angola 1
AR - Argentina 1
BY - Bielorussia 1
CY - Cipro 1
EC - Ecuador 1
GT - Guatemala 1
HU - Ungheria 1
IQ - Iraq 1
IS - Islanda 1
LT - Lituania 1
MU - Mauritius 1
NG - Nigeria 1
PE - Perù 1
TN - Tunisia 1
Totale 10.658
Salva come PNG Salva come JPEG
Città #
Southend 1.356
Chandler 420
Singapore 322
Seattle 243
Milan 240
Beijing 223
Princeton 204
Wilmington 193
Jacksonville 149
Dublin 139
Ann Arbor 121
Mountain View 121
Ashburn 116
Redmond 112
Nanjing 110
Frankfurt am Main 108
Fairfield 103
Santa Clara 91
Hong Kong 90
Toronto 86
Boardman 78
Phoenix 76
Warsaw 76
Munich 75
Sakarya 73
Woodbridge 72
Bengaluru 70
Dearborn 66
Des Moines 62
Medford 56
Shanghai 53
Serra 52
Andover 49
Bogotá 46
Somerville 40
Shenyang 38
Cambridge 36
Jakarta 35
Athens 34
Helsinki 34
Jinan 33
Houston 31
Nanchang 31
Eitensheim 30
Redwood City 30
Changsha 29
Brussels 27
New York 26
San Diego 24
Sunnyvale 24
Berlin 22
Hamburg 21
Odernheim 21
Rome 21
Tianjin 21
Hebei 20
Hanover 19
Guangzhou 18
Quanzhou 18
Roxbury 18
Bitonto 17
Fuzhou 17
Mumbai 17
São Paulo 17
London 16
Hangzhou 15
Chicago 14
Los Angeles 13
Turin 13
Grafing 12
Haikou 12
Wuhan 12
Zhengzhou 12
Kiez 11
Nuremberg 11
Falls Church 10
Jiaxing 10
Kunming 10
Norwalk 10
Nürnberg 10
Clifton 9
Ningbo 9
Ottawa 9
Portici 9
Seoul 9
Auburn Hills 8
Lanzhou 8
Paris 8
Scranton 8
Hefei 7
Highlands Ranch 7
Mainz 6
Maserà di Padova 6
Noginsk 6
Pisa 6
Taipei 6
Ankara 5
Baltimore 5
Boston 5
Bühl 5
Totale 6.552
Salva come PNG Salva come JPEG
Nome #
CD133+ cells isolated from various sources and their role in future clinical perspective 277
Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle 251
Modificazione genica di cellule staminali distrofiche allo scopo di trapianto autologo nella distrofia muscolare di Duchenne 238
Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy 209
Characterization of muscle-specific expression of miRNAs in duchenne muscular dystrophy 188
T and b lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse 184
Preliminary evidences of safety and efficacy of flavonoids- and omega 3-based compound for muscular dystrophies treatment: a randomized double-blind placebo controlled pilot clinical trial. 181
Advancements in stem cells treatment of skeletal muscle wasting 174
Morphological modifications of resected sciatic nerve after autologous transplantation of skin-derived stem cells into resorable guides. 168
Stem cells and muscular dystrophies 168
Expression of CD20 reveals a new store-operated calcium entry modulator in skeletal muscle 167
Correlation of circulanting CD133+ progenitor subclasses with a Mild phenotype in Duchenne Muscular dystrophy patients 163
Skin-derived stem cells transplanted into resorable guides provide functional nerve regeneration after sciatic nerve resection 161
Combining Stem Cell and Exon Skipping Approach to Treat Muscular Dystrophies 161
Abundance of circulating progenitors with myo-endothelial potential correlates with a mild phenotype in patients affected by Duchenne muscular dystrophy 158
VCAM-1 expression on dystrophic muscle vessels has a critical role in the recruitment of human blood-derived CD133+ stem cells after intra-arterial transplantation 149
CD20-related signaling pathway is differently activated in normal and dystrophic circulating CD133+ stem cells 148
Exome sequencing identifies variants in two genes encoding the LIM-proteins NRAP and FHL1 in an Italian patient with BAG3 myofibrillar myopathy 147
Combining stem cells and exon skipping strategy to treat muscular dystrophy 142
MicroRNA-206 is upregulated in an animal model of Duchenne Muscular Distrophy 140
The myomiR-206 partecipate to muscle-regeneration by sculpting the chromatin through the down.regulation of the non-histone chromatin-associated protein High Mobility group protein 3 (Hmgb3) 137
Cell Therapy of Muscular Dystrophy with Engineered CD133+ Cells 136
Perspectives of Stem Cell Therapy in Duchenne Muscular Dystrophy 132
Development of a new technique for muscle tissues-stem cells co-colture 132
MicroRNA-206 is upregulated in an animal model of Duchenne Muscular Distrophy. 131
Skin-derived stem cells transplanted into resorbable guides provide functional nerve regeneration after sciatic nerve resection 131
Differential Activativation of CD20-Related Signalling Pathway Results in Distinct Differentiation Behaviour of Normal and DMD Circulating CD133+ Stem Cells 131
Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model 131
The role of stem cells in muscular dystrophy 130
CD133+ Cells for the Treatment of Degenerative Diseases : update and perspectives 130
Cell Based Therapy for Duchenne Muscular Dystrophy 128
Development of new technologies Including myogenic differentiation of human circulating CD133+cells 128
Autologous transplantation of engineered muscle-derived CD133+ stem cells 125
Cell Theraphy of Muscolar Dystrophy with Engineered CD133+Cell 124
Abundance of Circulating Progenitors with Myo-Endothelial Potential Correlates with a Mild Phenotype in Patients Affected by Duchnne Muscular Dystrophy 124
Combining Gene and Stem Cell therapy in the Treatment of Dysferlinophaties 123
Absence of T and B lymphocytes enhances skeletal muscle regeneration and ameliorates dystrophic pathology in dysferlin deficient animal model 122
Hmgb3 Is Regulated by MicroRNA-206 during Muscle Regeneration 121
Differential Activation of CD20-related Signaling Pathways Results in distinct differentiation behaviour of normal and DMD circulating CD133+ Stem Cells 117
Preclinical experience and perspectives of a clinical trial using cD133 stem cells 117
Stem cell-mediated exon skipping of the dystrophin gene by the bystander effect 117
Muscle-specific microRNAs (mirnas) in Duchenne Muscular Distrophy (DMD). 115
MiRNAs dysregulation of Single Muscle Fibers in Duchenne Muscular Dystrophy 115
Mesenchymal Stem Cells as Muscle Reservoir 115
Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model 115
Impact of Muscular Dystrophy on the Regenerative Properties of interstitial Muscle Cells 115
Muscular dystrophies therapies by engineered stem cells 114
Ex vivo expansion of human circulating CD133+ progenitors cells: promising tool for cell-based therapeutic approaches in muscular dystrophy. 113
In Vivo Tracking of Stem cell by Nanotechnologies : Future Prospect for Mouse to Human Translation 113
Combining Stem Cells and Exon-Skipping and Approch to Treat Muscular Dystrophies 112
Ex vivo expansion of human circulanting CD133+promising tool for cell-based therapeutic approaches in muscular dystrophy 111
Exon-skipping of dysferlin in CD133+ stem cells isolated from normal and patient affected with dysferlinopathies. 111
Ex vivo expansion of peripheral blood CD133+ progenitors cells: promising tool for cell-based therapeutic approaches in muscular dystrophy. 110
Combining gene and stem cell therapy in the treatment of disferlinopaties 110
Role of Insulin-Like Growth Factor Receptor 2 across Muscle Homeostasis: Implications for Treating Muscular Dystrophy 110
Rescue of human dystrophin after transplantation of exon-skipping-engineered DMD stem cells in a dystrophic animal model 109
In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled CD133+ stem cell tropism to dystrophic muscle tissues using micro-CT imaging 109
Perturbation of calcium handling in CD133+ stem cells isolated from DMD blood 108
Human Fetal CD133+ Muscle Cells Expressing Perycite Markers Repair Dystrophic Muscle Tissue. 108
Myogenic differentiation potential of CD133+ stem cells isolated from various sources 107
Réhabilitation de la dystrophine humaine dans le modèle scid/mdx après greffe de cellules souches de patients DMD corrigées par saut d’exon 106
Exon-Skipping of Dysferlin in CD133+ Stem Cells Isolated from normal and patient affected with Dysferlinopathies 104
Proliferation and clonal Characterization of Human Muscle Derived CD133+ Stem Cell Define an Intrinsic Heterogeneity 104
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin‐deficient mice 102
MiRNAs Dysregulation of Single muscle fibers in Duchenne Muscular Dystrophy 102
Stem Cell Therapies to Treat Muscular Dystrophy : Progress to Date 100
Cell replacement therapy in neuromuscular and neurodegenerative diseases 100
Proliferation and Clonal Characterization of Human muscle Derived CD 133+ stem cell Define an Heterogeneity 99
Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice 98
Difference in Myogenic properties of the human blood-derived stem cells subpopulation isolated from normal and dystrophic tissues 92
Defective dystrophic thymus determines degenerative changes in skeletal muscle 91
Ex vivo expansion of human circulating myogenic progenitors on cluster-assembled nanostructured TiO2 88
Autologous transplantation of stem cells in DMD 88
Perturbation of calcium handling in CD133+ stem cells isolated from DMD blood 87
Exon-skipping of dysferlin in CD133+ stem cells isolated from normal and patient affected with dysferlinopathies 87
MicroRNA-206 is Upregulated in an Animal Model of Duchenne Muscular Dystrophy 87
Combining stem cells and exon skipping strategy to treat dystrophic GRMD dogs 86
Proliferation and clonal characterization of human muscle derived CD133+ positive stem cells define an intrinsic heterogeneity 85
Full-length dysferlin expression driven by engineered human dystrophic blood-derived CD133+ stem cells 85
Stem cell therapy of muscular dystrophies using exon skipping approach in GRMD dogs 81
Proliferation and Clonal Analysis of Muscle Derived CD133+ Stem Cell Subpopulations Define a Depletion of Mesenchymal Population in DMD Patients 80
Clinical applications of mesenchymal stem cells in chronic diseases 78
Stem cell-mediated exon skipping of the dystrophin gene by the bystander effect 78
Improvement of endurance of DMD animal model using natural polyphenols 76
Inhibition of the immunoproteasome modulates innate immunity to ameliorate muscle pathology of dysferlin-deficient BlAJ mice 74
Duchenne muscular dystrophy : isolation of CD133-expressing myogenic progenitors from blood and muscle of DMD patients 73
Full-Length Dysferlin Expression Driven by Engineered Human Dystrophic Blood-Derived CD133+ Stem Cells 73
Combining Stem Cells and Exon Skipping Strategy to Treat Muscular Dystrophy 68
Combining Stem Cells and Exon Skipping Strategy to Treat Muscular Dystrophy 67
Novel insight into stem cell trafficking in dystrophic muscles 65
Stem Cell Therapy for Neuromuscular Diseases 64
Role of Immunoglobulins in Muscular Dystrophies and Inflammatory Myopathies 56
Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases 53
Myogenic Cell Transplantation in Genetic and Acquired Diseases of Skeletal Muscle 53
Micro-CT technique for three-dimensional visualization of human stem cells 38
The immune system in duchenne muscular dystrophy pathogenesis 23
Advancing Biomarker Discovery and Therapeutic Targets in Duchenne Muscular Dystrophy: A Comprehensive Review 17
Flvcr1a deficiency promotes heme-based energy metabolism dysfunction in skeletal muscle 17
Totale 11.286
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.549
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020605 0 0 0 0 0 78 88 38 164 141 67 29
2020/20211.083 45 94 94 13 107 54 101 78 125 39 282 51
2021/20221.157 98 59 31 65 55 79 91 42 178 75 120 264
2022/20231.781 241 179 145 192 195 285 70 136 216 18 64 40
2023/2024966 38 73 44 73 300 56 46 42 10 61 90 133
2024/2025986 98 198 64 332 206 88 0 0 0 0 0 0
Totale 11.286